Ledger · 2026-08-29 · Biomaterials
Sustained-Release Silk Fibroin Microneedle Matrices via Lithium Bromide Extraction
Cleared
This concept cleared all seven gates and every voiding sub-test.
| Incumbent displaced | Hyaluronic acid microneedle matrix |
| Measured advantage | Structural dissolution time / delivery duration: Hyaluronic Acid MNs < 30 minutes vs Silk Fibroin MNs up to 100 days (>100x superior) |
| Time to first revenue | 8 months |
| Gross margin at parity | 95.3% |
| Startup CapEx | $45,000 |
The full analysis goes to the list
Mechanism, operating protocol with real conditions and yields, computed unit economics with a six-scenario stress test, the absence audit, and every resolved citation.
Assessed 2026-08-29 against seven gates plus the voiding sub-tests. How the method works · Browse all concepts